Vicapsys Life Sciences Inc (VICP)
OTHER OTC:VICP
US Market

Vicapsys Life Sciences (VICP) Stock Price & Analysis

0 Followers

VICP Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.51 - $4.39
Previous Close$2.46
Volume50.00
Average Volume (3M)N/A
Market Cap
$79.34M
Enterprise Value$79.33M
Total Cash (Recent Filing)$4.14K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-75.8
Beta1.16
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding32,315,742
10 Day Avg. Volume5
30 Day Avg. VolumeN/A
Standard Deviation2.91
R-Squared0.00634
Alpha0.51
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-78.89
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0


Financials

Annual

VICP FAQ

What was Vicapsys Life Sciences Inc’s price range in the past 12 months?
Vicapsys Life Sciences Inc lowest stock price was $0.51 and its highest was $4.39 in the past 12 months.
    What is Vicapsys Life Sciences Inc’s market cap?
    Currently, no data Available
    When is Vicapsys Life Sciences Inc’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were Vicapsys Life Sciences Inc’s earnings last quarter?
    Currently, no data Available
    Is Vicapsys Life Sciences Inc overvalued?
    According to Wall Street analysts Vicapsys Life Sciences Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does Vicapsys Life Sciences Inc pay dividends?
      Vicapsys Life Sciences Inc does not currently pay dividends.
      What is Vicapsys Life Sciences Inc’s EPS estimate?
      Vicapsys Life Sciences Inc’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Vicapsys Life Sciences Inc have?
      Vicapsys Life Sciences Inc has 32,315,742 shares outstanding.
        What happened to Vicapsys Life Sciences Inc’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of Vicapsys Life Sciences Inc?
        Currently, no hedge funds are holding shares in VICP

        ---

        Vicapsys Life Sciences Stock Smart Score

        N/A
        Not Ranked
        1
        2
        3
        4
        5
        6
        7
        8
        9
        10

        Technicals

        SMA
        Positive
        20 days / 200 days
        Momentum
        52.48%
        12-Months-Change

        Fundamentals

        Return on Equity
        Trailing 12-Months
        Asset Growth
        -86.76%
        Trailing 12-Months
        This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
        Learn more about TipRanks Smart Score

        Company Description

        Vicapsys Life Sciences Inc

        Vicapsys Life Sciences, Inc. is a development stage biotechnology company, which advances proprietary localized immune modulator. Its initial pipeline products include type 1 diabetes, post-surgical abdominal adhesion formation, and post-trauma keloid formation. The company was founded on December 26, 1996 and is headquartered in Cumming, GA.

        ---

        Forecast EPS vs Actual EPS

        Currently, no data available
        Please return soon. This page is being updated.

        Similar Stocks
        Company
        Price & Change
        Follow
        Aptose Biosciences
        Cormedix
        Xenon
        Marinus

        Popular Stocks

        ---
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis